Correlation Between Oracle and PolyPeptide Group
Can any of the company-specific risk be diversified away by investing in both Oracle and PolyPeptide Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oracle and PolyPeptide Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oracle and PolyPeptide Group AG, you can compare the effects of market volatilities on Oracle and PolyPeptide Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oracle with a short position of PolyPeptide Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oracle and PolyPeptide Group.
Diversification Opportunities for Oracle and PolyPeptide Group
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Oracle and PolyPeptide is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Oracle and PolyPeptide Group AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PolyPeptide Group and Oracle is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oracle are associated (or correlated) with PolyPeptide Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PolyPeptide Group has no effect on the direction of Oracle i.e., Oracle and PolyPeptide Group go up and down completely randomly.
Pair Corralation between Oracle and PolyPeptide Group
Given the investment horizon of 90 days Oracle is expected to generate 0.78 times more return on investment than PolyPeptide Group. However, Oracle is 1.28 times less risky than PolyPeptide Group. It trades about 0.17 of its potential returns per unit of risk. PolyPeptide Group AG is currently generating about -0.24 per unit of risk. If you would invest 16,959 in Oracle on September 4, 2024 and sell it today you would earn a total of 1,182 from holding Oracle or generate 6.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Oracle vs. PolyPeptide Group AG
Performance |
| Timeline |
| Oracle |
| PolyPeptide Group |
Oracle and PolyPeptide Group Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oracle and PolyPeptide Group
The main advantage of trading using opposite Oracle and PolyPeptide Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oracle position performs unexpectedly, PolyPeptide Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PolyPeptide Group will offset losses from the drop in PolyPeptide Group's long position.| Oracle vs. Palo Alto Networks | Oracle vs. Crowdstrike Holdings | Oracle vs. Microsoft | Oracle vs. Block Inc |
| PolyPeptide Group vs. Bachem Holding AG | PolyPeptide Group vs. Siegfried Holding | PolyPeptide Group vs. VAT Group AG | PolyPeptide Group vs. Comet Holding AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |